DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
ADA581581
Title:
Human Monoclonal Antibodies as a Countermeasure Against Botulinum Toxins
Descriptive Note:
Final rept. 1 Mar 2011-31 Aug 2012
Corporate Author:
MORPHOTEK INC EXTON PA
Report Date:
2012-11-30
Pagination or Media Count:
29.0
Abstract:
In this report, we summarize our studies to find novel, neutralizing antibodies against BoNTE, as well as the investigation into methods to generate cell lines expressing neutralizing antibodies or antibody-like molecules with specificities against BoNTA, B, and E. Through a series of rat and rabbit immunizations, we generated twelve recombinant MAbs capable of neutralizing 100LD50s of BoNTE in murine models. In parallel, multiple methods using both pro- and eukaryotic expression systems were tested for their ability to express neutralizing MAbs or MAb-like scaffolds with specificities against all three BoNTs. One system showing efficacy involved the generation of IgG-based expression constructs in which the full length light and heavy chains were expressed as a single amino acid sequence using a glycine-serine46 linker. Co-transfection of previously generated humanized BoNTA and B clones using this linker system in conjunction with dual selection markers showed that it was possible to generate a stable 293F cell line secreting both MAbs, which retained specificity to both toxins. Additionally, this material could be purified using traditional methods and mass spectrometry MS revealed both homo- and heterodimer pairing of the single chains via the hinge region of IgG. Lastly, two of the twelve BoNTE neutralizing MAbs were humanized and linked in a similar manner and tested for in vivo efficacy. One clone 199B13 was able to completely neutralize 100LD50s of BoNTE. This confirms the concept of the light-heavy chain linked IgG system and will permit the generation of a single production cell line generating material capable of neutralizing BoNTA, B, and E.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE
